Known Medicine Analysis: $7M Raised
What is Known Medicine?
Known Medicine employs machine learning and patient cell assays to forecast tumor drug responses, enhancing cancer treatment effectiveness.
Employees
17
Founded
2020
Revenue
$1.1M - <$5M
Product Features & Capabilities
- 3D cell culture dataset, machine learning-based sensitivity assay, micro-tumor platform, drug response prediction, personalized cancer treatment.
How much Known Medicine raised
Seed - $7.2 million
August 25, 2021Lead Investor: Caffeinated Capital, and others
Market Focus
Known Medicine primarily focuses on the biotechnology and pharmaceutical industry, specifically in the area of cancer treatment and drug response prediction using machine learning and -omics data.
Investors
- Caffeinated Capital
- Khosla Ventures
- Y Combinator
- Chris Gibson (Angel Investor)
Competitors Overview
Known Medicine operates in the precision medicine sector, specifically focusing on drug response prediction using machine learning and -omics data. Its main competitors include:
- Lantern Pharma: This company utilizes artificial intelligence and machine learning to enhance oncology drug discov
See something that needs updating? Suggest edits to this profile.